Global Coronary Drug Stent System Production, Demand and Key Producers, 2022-2028
It is used to treat narrowed or blocked blood vessels in the heart by reflowing blood through the blood vessels with an inflated balloon. A coronary stent is then placed into the vessel to ensure it remains open. Two types of stents are available, one that is coated with a drug to reduce the risk of future blockages (drug-eluting stents) and one that is uncoated (bare-metal stents).
This report studies the global Coronary Drug Stent System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Coronary Drug Stent System, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Coronary Drug Stent System that contribute to its increasing demand across many markets.
The global Coronary Drug Stent System market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Coronary Drug Stent System total production and demand, 2017-2028, (K Units)
Global Coronary Drug Stent System total production value, 2017-2028, (USD Million)
Global Coronary Drug Stent System production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Coronary Drug Stent System consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Coronary Drug Stent System domestic production, consumption, key domestic manufacturers and share
Global Coronary Drug Stent System production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Coronary Drug Stent System production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Coronary Drug Stent System production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Coronary Drug Stent System market based on the following parameters – headquarters, production locations, products portfolio, Coronary Drug Stent System revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Coronary Drug Stent System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Coronary Drug Stent System Market, By Region:
1. How big is the global Coronary Drug Stent System market?
2. What is the demand of the global Coronary Drug Stent System market?
3. What is the year over year growth of the global Coronary Drug Stent System market?
4. What is the production and production value of the global Coronary Drug Stent System market?
5. Who are the key producers in the global Coronary Drug Stent System market?
6. What are the growth factors driving the market demand?
This report studies the global Coronary Drug Stent System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Coronary Drug Stent System, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Coronary Drug Stent System that contribute to its increasing demand across many markets.
The global Coronary Drug Stent System market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Coronary Drug Stent System total production and demand, 2017-2028, (K Units)
Global Coronary Drug Stent System total production value, 2017-2028, (USD Million)
Global Coronary Drug Stent System production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Coronary Drug Stent System consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Coronary Drug Stent System domestic production, consumption, key domestic manufacturers and share
Global Coronary Drug Stent System production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Coronary Drug Stent System production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Coronary Drug Stent System production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Coronary Drug Stent System market based on the following parameters – headquarters, production locations, products portfolio, Coronary Drug Stent System revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Coronary Drug Stent System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Coronary Drug Stent System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- High Molecular Polymer Carrier
- No High Molecular Polymer Carrier
- Hospitals
- Clinics
- Medtronic
- Boston Scientific
- Biosensors
- Terumo
- MicroPort
- Lepu Medical
- B.Braun
- Atrium Medical
- SINOMED
- LBC
- Essen Technology
- Yinyi Biotech CO.,LTD.
1. How big is the global Coronary Drug Stent System market?
2. What is the demand of the global Coronary Drug Stent System market?
3. What is the year over year growth of the global Coronary Drug Stent System market?
4. What is the production and production value of the global Coronary Drug Stent System market?
5. Who are the key producers in the global Coronary Drug Stent System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Coronary Drug Stent System Introduction
1.2 World Coronary Drug Stent System Supply & Forecast
1.2.1 World Coronary Drug Stent System Production Value (2017 & 2021 & 2028)
1.2.2 World Coronary Drug Stent System Production (2017-2028)
1.2.3 World Coronary Drug Stent System Pricing Trends (2017-2028)
1.3 World Coronary Drug Stent System Production by Region
1.3.1 World Coronary Drug Stent System Production Value by Region (2017-2028)
1.3.2 World Coronary Drug Stent System Production by Region (2017-2028)
1.3.3 World Coronary Drug Stent System Average Price by Region (2017-2028)
1.3.4 North America Coronary Drug Stent System Production (2017-2028)
1.3.5 Europe Coronary Drug Stent System Production (2017-2028)
1.3.6 China Coronary Drug Stent System Production (2017-2028)
1.3.7 Japan Coronary Drug Stent System Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Coronary Drug Stent System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Coronary Drug Stent System Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Coronary Drug Stent System Demand (2017-2028)
2.2 World Coronary Drug Stent System Consumption by Region
2.2.1 World Coronary Drug Stent System Consumption by Region (2017-2022)
2.2.2 World Coronary Drug Stent System Consumption Forecast by Region (2023-2028)
2.3 United States Coronary Drug Stent System Consumption (2017-2028)
2.4 China Coronary Drug Stent System Consumption (2017-2028)
2.5 Europe Coronary Drug Stent System Consumption (2017-2028)
2.6 Japan Coronary Drug Stent System Consumption (2017-2028)
2.7 South Korea Coronary Drug Stent System Consumption (2017-2028)
2.8 ASEAN Coronary Drug Stent System Consumption (2017-2028)
2.9 India Coronary Drug Stent System Consumption (2017-2028)
3 WORLD CORONARY DRUG STENT SYSTEM MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Coronary Drug Stent System Production Value by Manufacturer (2017-2022)
3.2 World Coronary Drug Stent System Production by Manufacturer (2017-2022)
3.3 World Coronary Drug Stent System Average Price by Manufacturer (2017-2022)
3.4 Coronary Drug Stent System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Coronary Drug Stent System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Coronary Drug Stent System in 2021
3.5.3 Global Concentration Ratios (CR8) for Coronary Drug Stent System in 2021
3.6 Coronary Drug Stent System Market: Overall Company Footprint Analysis
3.6.1 Coronary Drug Stent System Market: Region Footprint
3.6.2 Coronary Drug Stent System Market: Company Product Type Footprint
3.6.3 Coronary Drug Stent System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Coronary Drug Stent System Production Value Comparison
4.1.1 United States VS China: Coronary Drug Stent System Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Coronary Drug Stent System Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Coronary Drug Stent System Production Comparison
4.2.1 United States VS China: Coronary Drug Stent System Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Coronary Drug Stent System Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Coronary Drug Stent System Consumption Comparison
4.3.1 United States VS China: Coronary Drug Stent System Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Coronary Drug Stent System Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Coronary Drug Stent System in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
4.5 China Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Coronary Drug Stent System in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Coronary Drug Stent System in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Coronary Drug Stent System Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 High Molecular Polymer Carrier
5.2.2 No High Molecular Polymer Carrier
5.3 Market Segment by Type
5.3.1 World Coronary Drug Stent System Production by Type (2017-2028)
5.3.2 World Coronary Drug Stent System Production Value by Type (2017-2028)
5.3.3 World Coronary Drug Stent System Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Coronary Drug Stent System Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Segment by Application
6.3.1 World Coronary Drug Stent System Production by Application (2017-2028)
6.3.2 World Coronary Drug Stent System Production Value by Application (2017-2028)
6.3.3 World Coronary Drug Stent System Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Coronary Drug Stent System Product and Services
7.1.4 Medtronic Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Boston Scientific
7.2.1 Boston Scientific Details
7.2.2 Boston Scientific Major Business
7.2.3 Boston Scientific Coronary Drug Stent System Product and Services
7.2.4 Boston Scientific Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Boston Scientific Recent Developments/Updates
7.2.6 Boston Scientific Competitive Strengths & Weaknesses
7.3 Biosensors
7.3.1 Biosensors Details
7.3.2 Biosensors Major Business
7.3.3 Biosensors Coronary Drug Stent System Product and Services
7.3.4 Biosensors Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biosensors Recent Developments/Updates
7.3.6 Biosensors Competitive Strengths & Weaknesses
7.4 Terumo
7.4.1 Terumo Details
7.4.2 Terumo Major Business
7.4.3 Terumo Coronary Drug Stent System Product and Services
7.4.4 Terumo Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Terumo Recent Developments/Updates
7.4.6 Terumo Competitive Strengths & Weaknesses
7.5 MicroPort
7.5.1 MicroPort Details
7.5.2 MicroPort Major Business
7.5.3 MicroPort Coronary Drug Stent System Product and Services
7.5.4 MicroPort Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 MicroPort Recent Developments/Updates
7.5.6 MicroPort Competitive Strengths & Weaknesses
7.6 Lepu Medical
7.6.1 Lepu Medical Details
7.6.2 Lepu Medical Major Business
7.6.3 Lepu Medical Coronary Drug Stent System Product and Services
7.6.4 Lepu Medical Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Lepu Medical Recent Developments/Updates
7.6.6 Lepu Medical Competitive Strengths & Weaknesses
7.7 B.Braun
7.7.1 B.Braun Details
7.7.2 B.Braun Major Business
7.7.3 B.Braun Coronary Drug Stent System Product and Services
7.7.4 B.Braun Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 B.Braun Recent Developments/Updates
7.7.6 B.Braun Competitive Strengths & Weaknesses
7.8 Atrium Medical
7.8.1 Atrium Medical Details
7.8.2 Atrium Medical Major Business
7.8.3 Atrium Medical Coronary Drug Stent System Product and Services
7.8.4 Atrium Medical Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Atrium Medical Recent Developments/Updates
7.8.6 Atrium Medical Competitive Strengths & Weaknesses
7.9 SINOMED
7.9.1 SINOMED Details
7.9.2 SINOMED Major Business
7.9.3 SINOMED Coronary Drug Stent System Product and Services
7.9.4 SINOMED Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 SINOMED Recent Developments/Updates
7.9.6 SINOMED Competitive Strengths & Weaknesses
7.10 LBC
7.10.1 LBC Details
7.10.2 LBC Major Business
7.10.3 LBC Coronary Drug Stent System Product and Services
7.10.4 LBC Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 LBC Recent Developments/Updates
7.10.6 LBC Competitive Strengths & Weaknesses
7.11 Essen Technology
7.11.1 Essen Technology Details
7.11.2 Essen Technology Major Business
7.11.3 Essen Technology Coronary Drug Stent System Product and Services
7.11.4 Essen Technology Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Essen Technology Recent Developments/Updates
7.11.6 Essen Technology Competitive Strengths & Weaknesses
7.12 Yinyi Biotech CO.,LTD.
7.12.1 Yinyi Biotech CO.,LTD. Details
7.12.2 Yinyi Biotech CO.,LTD. Major Business
7.12.3 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product and Services
7.12.4 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Yinyi Biotech CO.,LTD. Recent Developments/Updates
7.12.6 Yinyi Biotech CO.,LTD. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Coronary Drug Stent System and Key Manufacturers
8.2 Coronary Drug Stent System Manufacturing Costs
8.3 Coronary Drug Stent System Production Process
8.4 Coronary Drug Stent System Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Coronary Drug Stent System Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Coronary Drug Stent System Typical Distributors
9.3 Coronary Drug Stent System Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Coronary Drug Stent System Introduction
1.2 World Coronary Drug Stent System Supply & Forecast
1.2.1 World Coronary Drug Stent System Production Value (2017 & 2021 & 2028)
1.2.2 World Coronary Drug Stent System Production (2017-2028)
1.2.3 World Coronary Drug Stent System Pricing Trends (2017-2028)
1.3 World Coronary Drug Stent System Production by Region
1.3.1 World Coronary Drug Stent System Production Value by Region (2017-2028)
1.3.2 World Coronary Drug Stent System Production by Region (2017-2028)
1.3.3 World Coronary Drug Stent System Average Price by Region (2017-2028)
1.3.4 North America Coronary Drug Stent System Production (2017-2028)
1.3.5 Europe Coronary Drug Stent System Production (2017-2028)
1.3.6 China Coronary Drug Stent System Production (2017-2028)
1.3.7 Japan Coronary Drug Stent System Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Coronary Drug Stent System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Coronary Drug Stent System Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Coronary Drug Stent System Demand (2017-2028)
2.2 World Coronary Drug Stent System Consumption by Region
2.2.1 World Coronary Drug Stent System Consumption by Region (2017-2022)
2.2.2 World Coronary Drug Stent System Consumption Forecast by Region (2023-2028)
2.3 United States Coronary Drug Stent System Consumption (2017-2028)
2.4 China Coronary Drug Stent System Consumption (2017-2028)
2.5 Europe Coronary Drug Stent System Consumption (2017-2028)
2.6 Japan Coronary Drug Stent System Consumption (2017-2028)
2.7 South Korea Coronary Drug Stent System Consumption (2017-2028)
2.8 ASEAN Coronary Drug Stent System Consumption (2017-2028)
2.9 India Coronary Drug Stent System Consumption (2017-2028)
3 WORLD CORONARY DRUG STENT SYSTEM MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Coronary Drug Stent System Production Value by Manufacturer (2017-2022)
3.2 World Coronary Drug Stent System Production by Manufacturer (2017-2022)
3.3 World Coronary Drug Stent System Average Price by Manufacturer (2017-2022)
3.4 Coronary Drug Stent System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Coronary Drug Stent System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Coronary Drug Stent System in 2021
3.5.3 Global Concentration Ratios (CR8) for Coronary Drug Stent System in 2021
3.6 Coronary Drug Stent System Market: Overall Company Footprint Analysis
3.6.1 Coronary Drug Stent System Market: Region Footprint
3.6.2 Coronary Drug Stent System Market: Company Product Type Footprint
3.6.3 Coronary Drug Stent System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Coronary Drug Stent System Production Value Comparison
4.1.1 United States VS China: Coronary Drug Stent System Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Coronary Drug Stent System Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Coronary Drug Stent System Production Comparison
4.2.1 United States VS China: Coronary Drug Stent System Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Coronary Drug Stent System Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Coronary Drug Stent System Consumption Comparison
4.3.1 United States VS China: Coronary Drug Stent System Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Coronary Drug Stent System Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Coronary Drug Stent System in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
4.5 China Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Coronary Drug Stent System in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Coronary Drug Stent System Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Coronary Drug Stent System in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Coronary Drug Stent System Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 High Molecular Polymer Carrier
5.2.2 No High Molecular Polymer Carrier
5.3 Market Segment by Type
5.3.1 World Coronary Drug Stent System Production by Type (2017-2028)
5.3.2 World Coronary Drug Stent System Production Value by Type (2017-2028)
5.3.3 World Coronary Drug Stent System Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Coronary Drug Stent System Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Segment by Application
6.3.1 World Coronary Drug Stent System Production by Application (2017-2028)
6.3.2 World Coronary Drug Stent System Production Value by Application (2017-2028)
6.3.3 World Coronary Drug Stent System Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Coronary Drug Stent System Product and Services
7.1.4 Medtronic Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Boston Scientific
7.2.1 Boston Scientific Details
7.2.2 Boston Scientific Major Business
7.2.3 Boston Scientific Coronary Drug Stent System Product and Services
7.2.4 Boston Scientific Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Boston Scientific Recent Developments/Updates
7.2.6 Boston Scientific Competitive Strengths & Weaknesses
7.3 Biosensors
7.3.1 Biosensors Details
7.3.2 Biosensors Major Business
7.3.3 Biosensors Coronary Drug Stent System Product and Services
7.3.4 Biosensors Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biosensors Recent Developments/Updates
7.3.6 Biosensors Competitive Strengths & Weaknesses
7.4 Terumo
7.4.1 Terumo Details
7.4.2 Terumo Major Business
7.4.3 Terumo Coronary Drug Stent System Product and Services
7.4.4 Terumo Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Terumo Recent Developments/Updates
7.4.6 Terumo Competitive Strengths & Weaknesses
7.5 MicroPort
7.5.1 MicroPort Details
7.5.2 MicroPort Major Business
7.5.3 MicroPort Coronary Drug Stent System Product and Services
7.5.4 MicroPort Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 MicroPort Recent Developments/Updates
7.5.6 MicroPort Competitive Strengths & Weaknesses
7.6 Lepu Medical
7.6.1 Lepu Medical Details
7.6.2 Lepu Medical Major Business
7.6.3 Lepu Medical Coronary Drug Stent System Product and Services
7.6.4 Lepu Medical Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Lepu Medical Recent Developments/Updates
7.6.6 Lepu Medical Competitive Strengths & Weaknesses
7.7 B.Braun
7.7.1 B.Braun Details
7.7.2 B.Braun Major Business
7.7.3 B.Braun Coronary Drug Stent System Product and Services
7.7.4 B.Braun Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 B.Braun Recent Developments/Updates
7.7.6 B.Braun Competitive Strengths & Weaknesses
7.8 Atrium Medical
7.8.1 Atrium Medical Details
7.8.2 Atrium Medical Major Business
7.8.3 Atrium Medical Coronary Drug Stent System Product and Services
7.8.4 Atrium Medical Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Atrium Medical Recent Developments/Updates
7.8.6 Atrium Medical Competitive Strengths & Weaknesses
7.9 SINOMED
7.9.1 SINOMED Details
7.9.2 SINOMED Major Business
7.9.3 SINOMED Coronary Drug Stent System Product and Services
7.9.4 SINOMED Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 SINOMED Recent Developments/Updates
7.9.6 SINOMED Competitive Strengths & Weaknesses
7.10 LBC
7.10.1 LBC Details
7.10.2 LBC Major Business
7.10.3 LBC Coronary Drug Stent System Product and Services
7.10.4 LBC Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 LBC Recent Developments/Updates
7.10.6 LBC Competitive Strengths & Weaknesses
7.11 Essen Technology
7.11.1 Essen Technology Details
7.11.2 Essen Technology Major Business
7.11.3 Essen Technology Coronary Drug Stent System Product and Services
7.11.4 Essen Technology Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Essen Technology Recent Developments/Updates
7.11.6 Essen Technology Competitive Strengths & Weaknesses
7.12 Yinyi Biotech CO.,LTD.
7.12.1 Yinyi Biotech CO.,LTD. Details
7.12.2 Yinyi Biotech CO.,LTD. Major Business
7.12.3 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product and Services
7.12.4 Yinyi Biotech CO.,LTD. Coronary Drug Stent System Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Yinyi Biotech CO.,LTD. Recent Developments/Updates
7.12.6 Yinyi Biotech CO.,LTD. Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Coronary Drug Stent System and Key Manufacturers
8.2 Coronary Drug Stent System Manufacturing Costs
8.3 Coronary Drug Stent System Production Process
8.4 Coronary Drug Stent System Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Coronary Drug Stent System Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Coronary Drug Stent System Typical Distributors
9.3 Coronary Drug Stent System Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Coronary Drug Stent System Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Coronary Drug Stent System Production Value by Region (2017-2022) & (USD Million)
Table 3. World Coronary Drug Stent System Production Value by Region (2023-2028) & (USD Million)
Table 4. World Coronary Drug Stent System Production Value Market Share by Region (2017-2022)
Table 5. World Coronary Drug Stent System Production Value Market Share by Region (2023-2028)
Table 6. World Coronary Drug Stent System Production by Region (2017-2022) & (K Units)
Table 7. World Coronary Drug Stent System Production by Region (2023-2028) & (K Units)
Table 8. World Coronary Drug Stent System Production Market Share by Region (2017-2022)
Table 9. World Coronary Drug Stent System Production Market Share by Region (2023-2028)
Table 10. World Coronary Drug Stent System Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Coronary Drug Stent System Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Coronary Drug Stent System Major Market Trends
Table 13. World Coronary Drug Stent System Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Coronary Drug Stent System Consumption by Region (2017-2022) & (K Units)
Table 15. World Coronary Drug Stent System Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Coronary Drug Stent System Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Coronary Drug Stent System Producers in 2021
Table 18. World Coronary Drug Stent System Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Coronary Drug Stent System Producers in 2021
Table 20. World Coronary Drug Stent System Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Coronary Drug Stent System Company Evaluation Quadrant
Table 22. World Coronary Drug Stent System Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Coronary Drug Stent System Production Site of Key Manufacturer
Table 24. Coronary Drug Stent System Market: Company Product Type Footprint
Table 25. Coronary Drug Stent System Market: Company Product Application Footprint
Table 26. Coronary Drug Stent System Competitive Factors
Table 27. Coronary Drug Stent System New Entrant and Capacity Expansion Plans
Table 28. Coronary Drug Stent System Mergers & Acquisitions Activity
Table 29. United States VS China Coronary Drug Stent System Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Coronary Drug Stent System Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Coronary Drug Stent System Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Coronary Drug Stent System in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Coronary Drug Stent System in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Coronary Drug Stent System in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Coronary Drug Stent System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Coronary Drug Stent System Production by Type (2017-2022) & (K Units)
Table 49. World Coronary Drug Stent System Production by Type (2023-2028) & (K Units)
Table 50. World Coronary Drug Stent System Production Value by Type (2017-2022) & (USD Million)
Table 51. World Coronary Drug Stent System Production Value by Type (2023-2028) & (USD Million)
Table 52. World Coronary Drug Stent System Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Coronary Drug Stent System Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Coronary Drug Stent System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Coronary Drug Stent System Production by Application (2017-2022) & (K Units)
Table 56. World Coronary Drug Stent System Production by Application (2023-2028) & (K Units)
Table 57. World Coronary Drug Stent System Production Value by Application (2017-2022) & (USD Million)
Table 58. World Coronary Drug Stent System Production Value by Application (2023-2028) & (USD Million)
Table 59. World Coronary Drug Stent System Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Coronary Drug Stent System Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Medtronic Basic Information, Manufacturing Base and Competitors
Table 62. Medtronic Major Business
Table 63. Medtronic Coronary Drug Stent System Product and Services
Table 64. Medtronic Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Medtronic Recent Developments/Updates
Table 66. Medtronic Competitive Strengths & Weaknesses
Table 67. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 68. Boston Scientific Major Business
Table 69. Boston Scientific Coronary Drug Stent System Product and Services
Table 70. Boston Scientific Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Boston Scientific Recent Developments/Updates
Table 72. Boston Scientific Competitive Strengths & Weaknesses
Table 73. Biosensors Basic Information, Manufacturing Base and Competitors
Table 74. Biosensors Major Business
Table 75. Biosensors Coronary Drug Stent System Product and Services
Table 76. Biosensors Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biosensors Recent Developments/Updates
Table 78. Biosensors Competitive Strengths & Weaknesses
Table 79. Terumo Basic Information, Manufacturing Base and Competitors
Table 80. Terumo Major Business
Table 81. Terumo Coronary Drug Stent System Product and Services
Table 82. Terumo Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Terumo Recent Developments/Updates
Table 84. Terumo Competitive Strengths & Weaknesses
Table 85. MicroPort Basic Information, Manufacturing Base and Competitors
Table 86. MicroPort Major Business
Table 87. MicroPort Coronary Drug Stent System Product and Services
Table 88. MicroPort Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. MicroPort Recent Developments/Updates
Table 90. MicroPort Competitive Strengths & Weaknesses
Table 91. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 92. Lepu Medical Major Business
Table 93. Lepu Medical Coronary Drug Stent System Product and Services
Table 94. Lepu Medical Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Lepu Medical Recent Developments/Updates
Table 96. Lepu Medical Competitive Strengths & Weaknesses
Table 97. B.Braun Basic Information, Manufacturing Base and Competitors
Table 98. B.Braun Major Business
Table 99. B.Braun Coronary Drug Stent System Product and Services
Table 100. B.Braun Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. B.Braun Recent Developments/Updates
Table 102. B.Braun Competitive Strengths & Weaknesses
Table 103. Atrium Medical Basic Information, Manufacturing Base and Competitors
Table 104. Atrium Medical Major Business
Table 105. Atrium Medical Coronary Drug Stent System Product and Services
Table 106. Atrium Medical Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Atrium Medical Recent Developments/Updates
Table 108. Atrium Medical Competitive Strengths & Weaknesses
Table 109. SINOMED Basic Information, Manufacturing Base and Competitors
Table 110. SINOMED Major Business
Table 111. SINOMED Coronary Drug Stent System Product and Services
Table 112. SINOMED Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. SINOMED Recent Developments/Updates
Table 114. SINOMED Competitive Strengths & Weaknesses
Table 115. LBC Basic Information, Manufacturing Base and Competitors
Table 116. LBC Major Business
Table 117. LBC Coronary Drug Stent System Product and Services
Table 118. LBC Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. LBC Recent Developments/Updates
Table 120. LBC Competitive Strengths & Weaknesses
Table 121. Essen Technology Basic Information, Manufacturing Base and Competitors
Table 122. Essen Technology Major Business
Table 123. Essen Technology Coronary Drug Stent System Product and Services
Table 124. Essen Technology Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Essen Technology Recent Developments/Updates
Table 126. Yinyi Biotech CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 127. Yinyi Biotech CO.,LTD. Major Business
Table 128. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product and Services
Table 129. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Coronary Drug Stent System Raw Material
Table 131. Key Manufacturers of Coronary Drug Stent System Raw Materials
Table 132. Coronary Drug Stent System Typical Distributors
Table 133. Coronary Drug Stent System Typical Customers
Table 1. World Coronary Drug Stent System Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Coronary Drug Stent System Production Value by Region (2017-2022) & (USD Million)
Table 3. World Coronary Drug Stent System Production Value by Region (2023-2028) & (USD Million)
Table 4. World Coronary Drug Stent System Production Value Market Share by Region (2017-2022)
Table 5. World Coronary Drug Stent System Production Value Market Share by Region (2023-2028)
Table 6. World Coronary Drug Stent System Production by Region (2017-2022) & (K Units)
Table 7. World Coronary Drug Stent System Production by Region (2023-2028) & (K Units)
Table 8. World Coronary Drug Stent System Production Market Share by Region (2017-2022)
Table 9. World Coronary Drug Stent System Production Market Share by Region (2023-2028)
Table 10. World Coronary Drug Stent System Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Coronary Drug Stent System Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Coronary Drug Stent System Major Market Trends
Table 13. World Coronary Drug Stent System Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Coronary Drug Stent System Consumption by Region (2017-2022) & (K Units)
Table 15. World Coronary Drug Stent System Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Coronary Drug Stent System Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Coronary Drug Stent System Producers in 2021
Table 18. World Coronary Drug Stent System Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Coronary Drug Stent System Producers in 2021
Table 20. World Coronary Drug Stent System Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Coronary Drug Stent System Company Evaluation Quadrant
Table 22. World Coronary Drug Stent System Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Coronary Drug Stent System Production Site of Key Manufacturer
Table 24. Coronary Drug Stent System Market: Company Product Type Footprint
Table 25. Coronary Drug Stent System Market: Company Product Application Footprint
Table 26. Coronary Drug Stent System Competitive Factors
Table 27. Coronary Drug Stent System New Entrant and Capacity Expansion Plans
Table 28. Coronary Drug Stent System Mergers & Acquisitions Activity
Table 29. United States VS China Coronary Drug Stent System Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Coronary Drug Stent System Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Coronary Drug Stent System Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Coronary Drug Stent System in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Coronary Drug Stent System in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Coronary Drug Stent System in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Coronary Drug Stent System Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Coronary Drug Stent System Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Coronary Drug Stent System Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Coronary Drug Stent System Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Coronary Drug Stent System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Coronary Drug Stent System Production by Type (2017-2022) & (K Units)
Table 49. World Coronary Drug Stent System Production by Type (2023-2028) & (K Units)
Table 50. World Coronary Drug Stent System Production Value by Type (2017-2022) & (USD Million)
Table 51. World Coronary Drug Stent System Production Value by Type (2023-2028) & (USD Million)
Table 52. World Coronary Drug Stent System Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Coronary Drug Stent System Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Coronary Drug Stent System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Coronary Drug Stent System Production by Application (2017-2022) & (K Units)
Table 56. World Coronary Drug Stent System Production by Application (2023-2028) & (K Units)
Table 57. World Coronary Drug Stent System Production Value by Application (2017-2022) & (USD Million)
Table 58. World Coronary Drug Stent System Production Value by Application (2023-2028) & (USD Million)
Table 59. World Coronary Drug Stent System Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Coronary Drug Stent System Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Medtronic Basic Information, Manufacturing Base and Competitors
Table 62. Medtronic Major Business
Table 63. Medtronic Coronary Drug Stent System Product and Services
Table 64. Medtronic Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Medtronic Recent Developments/Updates
Table 66. Medtronic Competitive Strengths & Weaknesses
Table 67. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 68. Boston Scientific Major Business
Table 69. Boston Scientific Coronary Drug Stent System Product and Services
Table 70. Boston Scientific Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Boston Scientific Recent Developments/Updates
Table 72. Boston Scientific Competitive Strengths & Weaknesses
Table 73. Biosensors Basic Information, Manufacturing Base and Competitors
Table 74. Biosensors Major Business
Table 75. Biosensors Coronary Drug Stent System Product and Services
Table 76. Biosensors Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biosensors Recent Developments/Updates
Table 78. Biosensors Competitive Strengths & Weaknesses
Table 79. Terumo Basic Information, Manufacturing Base and Competitors
Table 80. Terumo Major Business
Table 81. Terumo Coronary Drug Stent System Product and Services
Table 82. Terumo Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Terumo Recent Developments/Updates
Table 84. Terumo Competitive Strengths & Weaknesses
Table 85. MicroPort Basic Information, Manufacturing Base and Competitors
Table 86. MicroPort Major Business
Table 87. MicroPort Coronary Drug Stent System Product and Services
Table 88. MicroPort Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. MicroPort Recent Developments/Updates
Table 90. MicroPort Competitive Strengths & Weaknesses
Table 91. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 92. Lepu Medical Major Business
Table 93. Lepu Medical Coronary Drug Stent System Product and Services
Table 94. Lepu Medical Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Lepu Medical Recent Developments/Updates
Table 96. Lepu Medical Competitive Strengths & Weaknesses
Table 97. B.Braun Basic Information, Manufacturing Base and Competitors
Table 98. B.Braun Major Business
Table 99. B.Braun Coronary Drug Stent System Product and Services
Table 100. B.Braun Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. B.Braun Recent Developments/Updates
Table 102. B.Braun Competitive Strengths & Weaknesses
Table 103. Atrium Medical Basic Information, Manufacturing Base and Competitors
Table 104. Atrium Medical Major Business
Table 105. Atrium Medical Coronary Drug Stent System Product and Services
Table 106. Atrium Medical Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Atrium Medical Recent Developments/Updates
Table 108. Atrium Medical Competitive Strengths & Weaknesses
Table 109. SINOMED Basic Information, Manufacturing Base and Competitors
Table 110. SINOMED Major Business
Table 111. SINOMED Coronary Drug Stent System Product and Services
Table 112. SINOMED Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. SINOMED Recent Developments/Updates
Table 114. SINOMED Competitive Strengths & Weaknesses
Table 115. LBC Basic Information, Manufacturing Base and Competitors
Table 116. LBC Major Business
Table 117. LBC Coronary Drug Stent System Product and Services
Table 118. LBC Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. LBC Recent Developments/Updates
Table 120. LBC Competitive Strengths & Weaknesses
Table 121. Essen Technology Basic Information, Manufacturing Base and Competitors
Table 122. Essen Technology Major Business
Table 123. Essen Technology Coronary Drug Stent System Product and Services
Table 124. Essen Technology Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Essen Technology Recent Developments/Updates
Table 126. Yinyi Biotech CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 127. Yinyi Biotech CO.,LTD. Major Business
Table 128. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Product and Services
Table 129. Yinyi Biotech CO.,LTD. Coronary Drug Stent System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Coronary Drug Stent System Raw Material
Table 131. Key Manufacturers of Coronary Drug Stent System Raw Materials
Table 132. Coronary Drug Stent System Typical Distributors
Table 133. Coronary Drug Stent System Typical Customers
LIST OF FIGURES
Figure 1. Coronary Drug Stent System Picture
Figure 2. World Coronary Drug Stent System Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Coronary Drug Stent System Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 5. World Coronary Drug Stent System Average Price (2017-2028) & (US$/Unit)
Figure 6. World Coronary Drug Stent System Production Value Market Share by Region (2017-2028)
Figure 7. World Coronary Drug Stent System Production Market Share by Region (2017-2028)
Figure 8. North America Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 9. Europe Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 10. China Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 11. Japan Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 12. Coronary Drug Stent System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Coronary Drug Stent System Demand (2017-2028) & (K Units)
Figure 15. World Coronary Drug Stent System Consumption Market Share by Region (2017-2028)
Figure 16. United States Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 17. China Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 18. Europe Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 19. Japan Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 20. South Korea Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 22. India Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Coronary Drug Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Coronary Drug Stent System Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Coronary Drug Stent System Markets in 2021
Figure 26. United States VS China: Coronary Drug Stent System Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Coronary Drug Stent System Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Coronary Drug Stent System Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Coronary Drug Stent System in United States
Figure 30. Key Producers and Market Share of Coronary Drug Stent System in China
Figure 31. Key Producers and Market Share of Coronary Drug Stent System in Rest of World
Figure 32. World Coronary Drug Stent System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Coronary Drug Stent System Production Value Market Share by Type in 2021
Figure 34. High Molecular Polymer Carrier
Figure 35. No High Molecular Polymer Carrier
Figure 36. World Coronary Drug Stent System Production Market Share by Type (2017-2028)
Figure 37. World Coronary Drug Stent System Production Value Market Share by Type (2017-2028)
Figure 38. World Coronary Drug Stent System Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Coronary Drug Stent System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Coronary Drug Stent System Production Value Market Share by Application in 2021
Figure 41. Hospitals
Figure 42. Clinics
Figure 43. World Coronary Drug Stent System Production Market Share by Application (2017-2028)
Figure 44. World Coronary Drug Stent System Production Value Market Share by Application (2017-2028)
Figure 45. World Coronary Drug Stent System Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Coronary Drug Stent System in 2021
Figure 47. Manufacturing Process Analysis of Coronary Drug Stent System
Figure 48. Coronary Drug Stent System Industrial Chain
Figure 49. Distribution Channel Breakdown for Coronary Drug Stent System Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Coronary Drug Stent System Picture
Figure 2. World Coronary Drug Stent System Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Coronary Drug Stent System Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 5. World Coronary Drug Stent System Average Price (2017-2028) & (US$/Unit)
Figure 6. World Coronary Drug Stent System Production Value Market Share by Region (2017-2028)
Figure 7. World Coronary Drug Stent System Production Market Share by Region (2017-2028)
Figure 8. North America Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 9. Europe Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 10. China Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 11. Japan Coronary Drug Stent System Production (2017-2028) & (K Units)
Figure 12. Coronary Drug Stent System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Coronary Drug Stent System Demand (2017-2028) & (K Units)
Figure 15. World Coronary Drug Stent System Consumption Market Share by Region (2017-2028)
Figure 16. United States Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 17. China Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 18. Europe Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 19. Japan Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 20. South Korea Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 22. India Coronary Drug Stent System Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Coronary Drug Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Coronary Drug Stent System Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Coronary Drug Stent System Markets in 2021
Figure 26. United States VS China: Coronary Drug Stent System Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Coronary Drug Stent System Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Coronary Drug Stent System Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Coronary Drug Stent System in United States
Figure 30. Key Producers and Market Share of Coronary Drug Stent System in China
Figure 31. Key Producers and Market Share of Coronary Drug Stent System in Rest of World
Figure 32. World Coronary Drug Stent System Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Coronary Drug Stent System Production Value Market Share by Type in 2021
Figure 34. High Molecular Polymer Carrier
Figure 35. No High Molecular Polymer Carrier
Figure 36. World Coronary Drug Stent System Production Market Share by Type (2017-2028)
Figure 37. World Coronary Drug Stent System Production Value Market Share by Type (2017-2028)
Figure 38. World Coronary Drug Stent System Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Coronary Drug Stent System Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Coronary Drug Stent System Production Value Market Share by Application in 2021
Figure 41. Hospitals
Figure 42. Clinics
Figure 43. World Coronary Drug Stent System Production Market Share by Application (2017-2028)
Figure 44. World Coronary Drug Stent System Production Value Market Share by Application (2017-2028)
Figure 45. World Coronary Drug Stent System Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Coronary Drug Stent System in 2021
Figure 47. Manufacturing Process Analysis of Coronary Drug Stent System
Figure 48. Coronary Drug Stent System Industrial Chain
Figure 49. Distribution Channel Breakdown for Coronary Drug Stent System Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
